August 22, 2026
How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink




After years of layoffs, cash burn and political attacks on its core technology, Modernaโ€™s melanoma vaccine data notched the biotech company a much-needed win.

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *